Pfizer (LIM:PFE) Other Current Payables: $0 Mil (As of Mar. 2026)


LIM:PFE Pfizer Inc LIM:PFE
55 GF Score
Price $23.89
GF Value $25.58
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Pfizer Other Current Payables?

Pfizer LIM:PFE 55 Other Current Payables is $0 Mil as of Mar. 2026. GuruFocus rates LIM:PFE with a GF Score™ of 55/100 and a GF Value™ of $25.58 (Fairly Valued). The stock has 5 warning signs investors should review.

Pfizer's Other Current Payables for the quarter that ended in Mar. 2026 was $0 Mil.

Pfizer's quarterly Other Current Payables increased from Sep. 2025 ($0 Mil) to Dec. 2025 ($2,445 Mil) but then declined from Dec. 2025 ($2,445 Mil) to Mar. 2026 ($0 Mil).

Pfizer's annual Other Current Payables increased from Dec. 2023 ($2,372 Mil) to Dec. 2024 ($2,437 Mil) and increased from Dec. 2024 ($2,437 Mil) to Dec. 2025 ($2,445 Mil).

Pfizer Other Current Payables Related Terms

Pfizer Other Current Payables Historical Data

* Premium members only.

The historical data trend for Pfizer's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer Other Current Payables Chart

Pfizer Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,249.00 2,303.00 2,372.00 2,437.00 2,445.00

Pfizer Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 2,445.00 0.00 2,445.00 0.00
LIM:PFE
55GF Score
Pfizer Inc LIM:PFE
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pfizer Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0 Mil mean?
Pfizer (LIM:PFE) has a Other Current Payables of $0 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Pfizer and its competitors.
Is Pfizer's Other Current Payables too high?
Pfizer's current Other Current Payables is $0 Mil. Overall, Pfizer has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pfizer's Other Current Payables compare to GILD and BMY?
Pfizer's Other Current Payables of $0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Pfizer and its competitors. Pfizer's current Other Current Payables is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pfizer stock overvalued right now?
Based on GuruFocus' analysis, Pfizer (LIM:PFE) is currently considered Fairly Valued. The stock's GF Value™ is $25.58, compared to a current price of $23.89 — trading 6.6% below its estimated fair value. The current Other Current Payables is $0 Mil. Pfizer's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Pfizer (LIM:PFE), the current Other Current Payables is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pfizer (LIM:PFE) Overvalued in 2026?

Based on GuruFocus' analysis, Pfizer stock appears to be undervalued. The current stock price of $23.89 is trading 6.6% below its estimated GF Value™ of $25.58. GuruFocus considers Pfizer to be Fairly Valued.

Key valuation signals for LIM:PFE:

  • Other Current Payables: $0 Mil
  • GF Value™: $25.58 vs. price of $23.89 (6.6% below fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the LIM:PFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pfizer Business Description

Address 66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
55GF Score

Get the complete analysis for LIM:PFE

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.89
Price
$25.58
GF Value